Caplin Steriles gets USFDA EIR
Caplin Steriles, a wholly-owned subsidiary of Caplin Point Laboratories, has received the Establishment Inspection Report from the US Food and Drug Ad25-07-2019
25-07-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1560 Name of the Signatory :- Vinod Kumar SDesignation :- Company Secretary and Compliance Officer18-07-2019
Caplin Point Laboratories Ltd - 524742 - Shareholding for the Period Ended June 30, 2019
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here17-07-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate/Duplicate certificate.12-07-2019
Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate/Duplicate certificate.12-07-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window
Closure of Trading Window29-06-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - DISCLOSURE OF RELATED PARTY TRANSACTIONS
DISCLOSURE OF RELATED PARTY TRANSACTIONS PURSUANT TO REGULATION 23(9) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS,201520-06-2019